Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdelhak Elkhazraji"'
Autor:
Abdelhak Elkhazraji, Sara Rharrit, Jean Uwingabiye, Hafid Zahid, Azeddine Ibrahimi, Nezha Messaoudi
Publikováno v:
International Journal of Medical Research and Health Sciences, Vol 7, Iss 3, Pp 66-72 (2018)
The initiation of treatment with acenocoumarol is a critical phase that can lead to an iatrogenic event in some patients carrying polymorphisms of the genes involved in the response to treatment, notably VKORC1 and CYP2C9. We report the first case in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c5012b36fa4e0ff2939b7975cb9d94b1
http://www.ijmrhs.com/medical-research/hypersensitivity-to-acenocoumarol-revealing-a-homozygous-mutation-for-vkorc1--1639-g--a-and-vkorc1-1173-c--t-and-heteroz.pdf
http://www.ijmrhs.com/medical-research/hypersensitivity-to-acenocoumarol-revealing-a-homozygous-mutation-for-vkorc1--1639-g--a-and-vkorc1-1173-c--t-and-heteroz.pdf
Autor:
Mohamed El Amrani, Mohammed Benyahia, Hafid Zahid, Abdelhak Elkhazraji, Rachid Hadef, Jean Uwingabiye, Fayçal Labrini, Nezha Messaoudi, D. Kabbaj, Anass Yahyaoui
Publikováno v:
BMC Hematology
BMC Hematology, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Hematology, Vol 18, Iss 1, Pp 1-8 (2018)
Background The acquired inhibitors of coagulation have been observed in very rare cases of monoclonal gammopathies. We report a very rare case of anti-factor XI antibodies in patient with plasma cell leukemia (PCL). Case presentation This is a 59-yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497fae1f8582c0c12f83e9bb3d79c929
https://doi.org/10.1186/s12878-018-0100-9
https://doi.org/10.1186/s12878-018-0100-9
Autor:
Abdelhak, Elkhazraji, El Arbi, Bouaiti, Hassan, Boulahyaoui, Christiana Philippa, Nahmtchougli, Hafid, Zahid, Mounia, Bensaid, Azeddine, Ibrahimi, Nezha, Messaoudi
Publikováno v:
Drug discoveriestherapeutics. 12(2)
We investigated the impact of non-genetics factors, and single nucleotide polymorphisms (SNPs) in VKORC1, CYP2C9, CYP4F2, and GGCX on acenocoumarol dosage in Moroccan adult's patients, in order to develop an algorithm to predict acenocoumarol dose fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96495aa265be72b1404b77fb184c7919
https://pubmed.ncbi.nlm.nih.gov/29760340
https://pubmed.ncbi.nlm.nih.gov/29760340